Prosper HealthTech Accelerator Summer 2026

Prosper HealthTech Accelerator Summer 2026 is a healthcare-focused accelerator cohort based in Birmingham, Alabama for startups creating cutting-edge health technology. The program invests in five high-growth startups per cohort and is positioned to support early-stage founders tackling major healthcare challenges. The program provides resources, network access, and coaching to help founders build impactful solutions in healthcare. The page lists structured programming, including weekly cohort sessions and bi-weekly one-on-one mentorship, and includes a Premiere Night pitch event.

Key Benefits

• Office space within Prosper’s headquarters
• Twelve weeks of individualized coaching and mentorship during bi-weekly, one-on-one meetings
• One-on-one meetings with 100+ connections including serial entrepreneurs, industry experts and investors
• Weekly cohort programming (e.g., understanding market size, choosing a revenue model, and how to pitch investors)
• Exclusive Premiere Night reception where companies pitch to entrepreneurs, mentors, investors and community members
• $1M+ in deals and perks from vendors like IBM Cloud, Rackspace, Amazon, PayPal, Zendesk, Hubspot and Microsoft
• Access to gener8tor’s global network of investors and mentors

Eligibility

• Startups creating cutting-edge health technology
• Early-stage companies tackling major healthcare challenges

Program Structure

• 12-week accelerator program
• Cohort size: five high-growth startups (per cohort)
• Bi-weekly, one-on-one coaching and mentorship
• Weekly cohort programming sessions
• Premiere Night pitch event

Dates & Duration

• Program duration: 12 weeks
• Program start date: 2026-06-18 (Program Kickoff)
• Any key milestones: Application Deadline (April 26, 2026); Program End (September 4, 2026)

Investment terms listed: $50,000 for 5% of the Common Equity (required to participate) plus an optional $40,000 convertible note for $90,000 total initial investment. Another section lists: $60K in exchange for 6% common stock equity. Managing Director listed: Amanda Williams ([email protected]). The page highlights Birmingham’s healthcare ecosystem and notes Birmingham is home to over 1,500 clinical trials and 75+ healthcare companies.